161 related articles for article (PubMed ID: 29345921)
1. Molecular Mechanisms in the Selectivity of Nonsteroidal Anti-Inflammatory Drugs.
Shamsudin Y; Gutiérrez-de-Terán H; Åqvist J
Biochemistry; 2018 Feb; 57(7):1236-1248. PubMed ID: 29345921
[TBL] [Abstract][Full Text] [Related]
2. Probing the Time Dependency of Cyclooxygenase-1 Inhibitors by Computer Simulations.
Shamsudin Y; Gutiérrez-de-Terán H; Åqvist J
Biochemistry; 2017 Apr; 56(13):1911-1920. PubMed ID: 28304156
[TBL] [Abstract][Full Text] [Related]
3. Toward an optimal docking and free energy calculation scheme in ligand design with application to COX-1 inhibitors.
Shamsudin Y; Gutiérrez-de-Terán H; Boukharta L; Åqvist J
J Chem Inf Model; 2014 May; 54(5):1488-99. PubMed ID: 24786949
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the mechanism behind the varied binding activities of COXIBs through Molecular Dynamic Simulations, MM-PBSA binding energy calculations and per-residue energy decomposition studies.
Chaudhary N; Aparoy P
J Biomol Struct Dyn; 2017 Mar; 35(4):868-882. PubMed ID: 26982261
[TBL] [Abstract][Full Text] [Related]
5. Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.
Rimon G; Sidhu RS; Lauver DA; Lee JY; Sharma NP; Yuan C; Frieler RA; Trievel RC; Lucchesi BR; Smith WL
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):28-33. PubMed ID: 19955429
[TBL] [Abstract][Full Text] [Related]
6. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
Zambre AP; Ganure AL; Shinde DB; Kulkarni VM
J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838
[TBL] [Abstract][Full Text] [Related]
7. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
[TBL] [Abstract][Full Text] [Related]
8. Origin of the Enigmatic Stepwise Tight-Binding Inhibition of Cyclooxygenase-1.
Shamsudin Y; Kazemi M; Gutiérrez-de-Terán H; Åqvist J
Biochemistry; 2015 Dec; 54(49):7283-91. PubMed ID: 26562384
[TBL] [Abstract][Full Text] [Related]
9. Docking Studies, Synthesis and Biological Evaluation of β-aryl-β-hydroxy Propanoic Acids for Anti-inflammatory Activity.
Savic J; Dilber S; Milenkovic M; Kotur-Stevuljevic J; Markovic B; Vladimirov S; Brboric J
Med Chem; 2017; 13(2):186-195. PubMed ID: 27605092
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
Abdel-Aziz AA; ElTahir KE; Asiri YA
Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
[TBL] [Abstract][Full Text] [Related]
11. COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles.
Oniga SD; Pacureanu L; Stoica CI; Palage MD; Crăciun A; Rusu LR; Crisan EL; Araniciu C
Molecules; 2017 Sep; 22(9):. PubMed ID: 28891941
[TBL] [Abstract][Full Text] [Related]
12. Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors.
Kalgutkar AS; Marnett AB; Crews BC; Remmel RP; Marnett LJ
J Med Chem; 2000 Jul; 43(15):2860-70. PubMed ID: 10956194
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS
Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition.
Limongelli V; Bonomi M; Marinelli L; Gervasio FL; Cavalli A; Novellino E; Parrinello M
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5411-6. PubMed ID: 20215464
[TBL] [Abstract][Full Text] [Related]
15. 2-Substituted Benzoxazoles as Potent Anti-Inflammatory Agents: Synthesis, Molecular Docking and In vivo Anti-Ulcerogenic Studies.
Hamid I; Nadeem H; Ansari SF; Khiljee S; Abbasi I; Bukhari A; Arif M; Imran M
Med Chem; 2022; 18(7):791-809. PubMed ID: 34931968
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives.
Moraes ADTO; Miranda MDS; Jacob ÍTT; Amorim CADC; Moura RO; Silva SÂSD; Soares MBP; Almeida SMV; Souza TRCL; Oliveira JF; Silva TGD; Melo CML; Moreira DRM; Lima MDCA
Bioorg Med Chem; 2018 Nov; 26(20):5388-5396. PubMed ID: 30293795
[TBL] [Abstract][Full Text] [Related]
17. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.
Rao P; Knaus EE
J Pharm Pharm Sci; 2008 Sep; 11(2):81s-110s. PubMed ID: 19203472
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclooxygenase by blocking the reducing cosubstrate at the peroxidase site: Discovery of galangin as a novel cyclooxygenase inhibitor.
Bai HW; Yang C; Wang P; Rao S; Zhu BT
Eur J Pharmacol; 2021 May; 899():174036. PubMed ID: 33737009
[TBL] [Abstract][Full Text] [Related]
19. In situ click chemistry generation of cyclooxygenase-2 inhibitors.
Bhardwaj A; Kaur J; Wuest M; Wuest F
Nat Commun; 2017 Feb; 8(1):1. PubMed ID: 28232747
[TBL] [Abstract][Full Text] [Related]
20. Structure-based QSAR study on differential inhibition of human prostaglandin endoperoxide H synthase-2 (COX-2) by nonsteroidal anti-inflammatory drugs.
Pouplana R; Lozano JJ; Pérez C; Ruiz J
J Comput Aided Mol Des; 2002 Oct; 16(10):683-709. PubMed ID: 12650588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
